Effect of an alkaloidal fraction of Tabernaemontana elegans (Stapf.) on selected micro-organisms

Journal of Ethnopharmacology

Volumn 140, Issue 2, 2012, Pages 398-404

  Pallant, C A ^a   Cromarty, A D ^a   Steenkamp, V ^a  

^a UNIVERSITY OF PRETORIA   (South Africa)

Author keywords

Antibacterial; Indole alkaloids; Methicillin resistant Staphylococcus aureus; Mycobacteria; Respiratory; Tabernaemontana elegans; Tuberculosis

Indexed keywords

ALKALOID DERIVATIVE; AMPICILLIN; ANTIINFECTIVE AGENT; DREGAMINE; INDOLE ALKALOID; PLANT EXTRACT; TABERNAEMONTANA ELEGANS EXTRACT; UNCLASSIFIED DRUG; VOACANGINE;

ANTIBACTERIAL ACTIVITY; ARTICLE; BACILLUS SUBTILIS; CANCER CELL CULTURE; CELL CULTURE; CELL VIABILITY; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG EFFECT; DRUG POTENTIATION; ENTEROCOCCUS FAECALIS; ESCHERICHIA COLI; HUMAN; HUMAN CELL; IC 50; KLEBSIELLA PNEUMONIAE; MASS FRAGMENTOGRAPHY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; MYCOBACTERIUM SMEGMATIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PLANT ROOT; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS; TABERNAEMONTANA; TABERNAEMONTANA ELEGANS;

ANTI-BACTERIAL AGENTS; CELL LINE; CHROMATOGRAPHY, THIN LAYER; FIBROBLASTS; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; GRAM-POSITIVE BACTERIA; HEP G2 CELLS; HUMANS; IBOGAINE; INDOLE ALKALOIDS; INHIBITORY CONCENTRATION 50; LYMPHOCYTES; MACROPHAGES; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM; PLANT EXTRACTS; PLANT ROOTS; TABERNAEMONTANA;

BACTERIA (MICROORGANISMS); CORYNEBACTERINEAE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MYCOBACTERIUM; POSIBACTERIA; TABERNAEMONTANA ELEGANS;

EID: 84858009111     PISSN: 03788741     EISSN: 18727573     Source Type: Journal    
DOI: 10.1016/j.jep.2012.01.036     Document Type: Article

References (53)

1. Anderson, R., Smit, M.J., Van Rensberg, C.E.J., 1993. Lysophospholipid-mediated inhibition of Na+, K(+)-adenosine triphosphatase is a possible mechanism of the immunosuppressive activity of cyclosporine A. Molecular Pharmacology 44, 605-619.
2. Anhalt, J.P., Sabath, L.D., Barry, A.L., 1980. In: Lennette, E.H., Balows, A., Hausler Jr., W.J. (Eds.), Manual of Clinical Microbiology., 3rd ed. American Society for Microbiology, Washington, DC, pp. 453-458.
3. Ankli, A., Heinrich, M., Bork, P., Wolfram, L., Bauerfeind, P., Brun, R., Schmid, C., Weiss, C., Bruggisser, R., Gertsch, J., Wasescha, M., Sticher, O., 2002. Yucatec Mayan medicinal plants: evaluation based on indigenous uses. Journal of Ethnopharmacology 79, 43-52. (Pubitemid 34017239)
4. Arnold, H.J., Gulumian, M., 1984. Pharmacopoeia of traditional medicine in Venda. Journal of Ethnopharmacology 12, 35-74. (Pubitemid 14046619)
5. Bombardelli, E., Bonati, A., Gabetta, B., Martinelli, E.M., Mustich, G., Danieli, B., 1976. Structures of tabernaelegantines A-D and tabernaelegantinines A and B, new indole alkaloids from Tabernaemontana elegans. Journal of the Chemical Society, Perkin Transactions 13, 1432-1438.
6. Bonapace, C.R., White, R.L., Friedrich, L.V., Bosso, J.A., 2000. Evaluation of the antibiotic synergy against Acinetobacter baumanii: a comparison with E-test, time-kill, and checkerboard methods. Diagnostic Microbiology and Infectious Disease 38, 43-50.
7. Borenfreund, E., Puerner, J.A., 1986. Cytotoxicity of metals, metal-metal and metal chelator combinations assays in vitro. Toxicology 39, 121-134. (Pubitemid 16104298)
8. Cardoso, C.A.L., Vilegas, W., Honda, N.K., 1998. Qualitative determination of indole alkaloids, triterpenoids and steroids of Tabernaemontana hilariana. Journal of Chromatography A 808, 264-268. (Pubitemid 28273242)
9. Chattipakorn, S., Pongpanparadorn, A., Pratchayasakul, W., Pongchaidacha, A., Ingkaninan, K., Chattipakorn, N., 2007. Tabernaemontana divaricata extracts inhibits neuronal acetylcholinesterase activity in rats. Journal of Ethnopharmacology 110, 61-68. (Pubitemid 46209570)
10. Chaturvedula, V.S.P., Sprague, S., Schilling, J.K., Kingston, D.G.I., 2003. New cytotoxic indole alkaloids from Tabernaemontana calcarea from the Madagascar rainforest. Journal of Natural Products 66, 528-531. (Pubitemid 36531903)
11. Coats Palgrave, K.C., Drummond, R.B., Moll, E.J., Coats Palgrave, M., 2003. Trees of Southern Africa, 3rd ed. New Holland Publishers, Cape Town.
12. Dagnino, D., Schripsema, J., Verpoorte, R., 1995. Terpenoidindole alkaloid biosynthesis and enzyme activities in two cell lines of Tabernaemontana divaricata. Phytochemistry 39, 341-349.
13. Danieli, B., Palmisano, G., Gabetta, B., Martinelli, E.M., 1980. Tabernaelegantinines C and D, two new bisindole alkaloids containing a cyano group from Tabernaemontana elegans Stapf. Part 2. Journal of the Chemical Society, Perkin Transactions 1 (2), 601-606.
14. Dorman, S.E., Chaisson, R.E., 2007. From magic bullets back to the Magic Mountain: the rise of extensively drug-resistant tuberculosis. Nature Medicine 13, 295-298. (Pubitemid 46376673)
15. Fulton, D.C., Kroon, P.A., Threlfall, D.R., 1994. Enzymological aspects of the redirection of terpenoid biosynthesis in elicitor-treated cultures of Tabernaemontana divaricata. Phytochemistry 35, 1183-1186. (Pubitemid 2065894)
16. Gabetta, B., Martinelli, E.M., Mustich, G., 1975. Plants of Mozambique, VII. Alkaloids of Tabernaemontana elegans. Fitoterapia 46, 195-198.
17. Gemmel, C.G., Edwards, D.I., Fraise, A.P., Gould, F.K., Ridgway, G.L., Warren, R.E., 2006. Guidelines for the prophylaxis and treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in the UK. Journal of Antimicrobial Chemotherapy 57, 589-608.
18. Gold, H.S., Moellering, R.C., 1996. Antimicrobial-drug resistance. New England Journal of Medicine 355, 1445-1454. (Pubitemid 26382507)
19. Hageman, J.C., Uyeki, T.M., Francis, J.S., Jernigan, D.B., Wheeler, J.G., Bridges, C.B., Barenkamp, S.J., Sievert, D.M., Srinivasan, A., Doherty, M.C., McDougal, L.K., Killgore, G.E., Lopatin, U.A., Coffman, R., MacDonald, J.K., McAllister, S.K., Fosheim, G.E., Patel, J.B., McDonald, L.C., 2006. Severe community-acquired pneumonia due to Staphylococcus aureus, 2003-04 influenza season. Emerging Infectious Disease 12, 894-899. (Pubitemid 43848409)
20. Harborne, J.B., 1998. Phytochemical Methods, 3rd ed. Chapman & Hall, London.
21. Hawkey, P.M., Jones, A.M., 2009. The changing epidemiology of resistance. Journal of Antimicrobial Chemotherapy 64 (Suppl. 1), i3-i10.
22. Johnson, R., Streicher, E.M., Louw, G.E., Warren, R.M., van Helden, P.D., Victor, T.C., 2006. Drug resistance in Mycobacterium tuberculosis. Current Issues in Molecular Biology 8, 97-112. (Pubitemid 44121991)
23. Kingston, D.G.I., Gerhard, B.B., Ionescu, F., Mangino, M.M., Sami, S.M., 1978. Plant anticancer agents V: New bisindole alkaloids from Tabernaemontana johnstonii stem bark. Journal of Pharmaceutical Sciences 67, 249-251. (Pubitemid 8309100)
24. Kingston, D.G.I., 1978. Plant anticancer agents VI: Isolation of voacangine, voacamine, and epivoacorine from Tabernaemontana arborea sap. Journal of Pharmaceutical Sciences 67, 271-272. (Pubitemid 8309110)
25. Kuo, Y.C., Sun, C.M., Tsai, W.J., Ou, J.C., Chen, W.P., Lin, C.Y., 1999. Blocking of cell proliferation, cytokine production and gene expression following administration of Chinese herbs in human mesangial cells. Life Science 64, 2089-2099.
26. Lee, C.C., Houghton, P., 2005. Cytotoxicity of plants from Malaysia and Thailand used traditionally to treat cancer. Journal of Ethnopharmacology 10, 237-243. (Pubitemid 41206617)
27. Lucumi, E., Luczkiewicz, M., Vera, A., Hallard, R., Van der Heijden, R., Verpoorte, R., 2001. Alkaloid formation in cell suspension cultures of Tabernaemontana divaricate after feeding of tryptamine and loganin. Biotechnology Annual Review 23, 1961-1966.
28. Mederios, W.L.B., Vieira, I.J.C., Mathias, L., Braz-Filho, R., Schripsema, J., 2001. A new natural quaternary indole alkaloid isolated from Tabernaemontana laeta Mart. (Apocynaceae). Journal of the Brazilian Chemical Society 12, 367-372.
29. Mosmann, T., 1983. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. Journal of Immunological Methods 65, 55-63. (Pubitemid 14203433)
30. Nannini, E., Murray, B.E., Arias, C.A., 2010. Resistance or decreased susceptibility to glycopeptides, daptomycin and linezolid in methicillin-resistant Staphylococcus aureus. Current Opinion in Pharmacology 10, 516-521.
31. National Committee for Clinical Laboratory Standards, 2008. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; Document M07-A8.CLSI, Wayne, PA.
32. Neuwinger, N.D., 1966. African Traditional Medicine, 1st ed. Medpharm Scientific Publishers, Stuttgart.
33. Pallant, C.A., 2010. Bioactivity of the alkaloidal fraction of Tabernaemontana elegans (Stapf.). MSc thesis, University of Pretoria, Pretoria.
34. Pallant, C.A., Steenkamp, V., 2008. In vitro bioactivity of Venda medicinal plants used in the treatment of respiratory conditions. Human and Experimental Toxicology 27, 859-866.
35. Pereira, C.G., Marques, M.O.M., Barreto, A.S., Siani, A.C., Fernandes, E.C., Meireles, M.A.A., 2004. Extraction of indole alkaloids from Tabernaemontana catharinensis using supercritical CO2 plus ethanol: an evaluation of the process variables and the raw material origin. Journal of Supercritical Fluids 30, 51-61.
36. Pereira, C.G., Leal, P.F., Sato, D.N., Meireles, M.A.A., 2005. Antioxidant and antimycobacterial activities of Tabernaemontana catharinensis extracts obtained by supercritical CO2 plus cosolvent. Journal of Medicinal Food 8, 533-538. (Pubitemid 43121909)
37. Rastogi, N., Abaul, J., Goh, K.S., Devallois, A., Philogène, E., Bourgeois, P., 1998. Antimycobacterial activity of chemically defined substances from the Carribbean flora in Guadelope. FEMS Immunology & Medical Microbiology 20, 267-273. (Pubitemid 28206333)
38. Ruttoh, E.K., Tarus, P.K., Bii, C.C., Machocho, A.K., Karimi, L.K., Okemo, P.O., 2009. Antibacterial activity of Apocynaceae extracts and MIC of Tabernaemontana angulate stem organic extract. African Journal of Traditional, Complementary and Alternative Medicines 6, 186-194.
39. Salgado, C.D., Farr, B.M., Calfee, D.P., 2003. Community-acquired Methicillin-resistant Staphylococcus aureus: A meta-analysis of prevalence and risk-factors. Clinical Infectious Diseases 36, 131-139. (Pubitemid 36143409)
40. Sefton, A.M., 2002. Mechanisms of antimicrobial resistance: their clinical relevance in the new millennium. Drugs 62, 557-566. (Pubitemid 34264025)
41. Siddiqi, S.H., Libonati, J.P., Middlebrook, G., 1981. Evaluation of a rapid radiometric method for drug susceptibility testing of Mycobacterium tuberculosis. Journal of Clinical Microbiology 13, 908-913.
42. Stahl, E., 1969. Thin Layer Chromatography, 2nd ed. Springer-Verlag, Berlin.
43. Steenkamp, V., Fernandes, A.C., Van Rensberg, C.E.J., 2007. Screening of Venda medicinal plants for antifungal activity against Candida albicans. South African Journal of Botany 73, 256-258. (Pubitemid 46509811)
44. Thind, T.S., Agrawa, S.K., Saxena, A.K., Arora, S., 2008. Studies on cytotoxic, hydroxyl-radical scavenging and topoisomerase inhibitory activities of extracts of Tabernaemontana divericata(L.)R.br. ex. Roem. and Schult. Food and Chemical Toxicology 46, 2922-2927.
45. Van Beek, T.A., Deelder, A.M., Verpoorte, R., Baerheim Svendson, A., 1984. Antimicrobial, antiamoebic and antiviral screening of some Tabernaemontana species. Planta Medica 50, 180-185. (Pubitemid 14064518)
46. Van Beek, T.A., Verpoorte, R., Baerheim Svendson, A., 1985. Antimicrobially active alkaloids from Tabernaemontana chippii. Journal of Natural Products 48, 400-423. (Pubitemid 15018849)
47. Van der Heijden, R., Brouwer, R.L., Verpoorte, R., 1986. Indole alkaloids from Tabernaemontana elegans. Planta Medica 2, 144-147. (Pubitemid 16110503)
48. Watt, J.M., Breyer-Brandwijk, M.G., 1962. The Medicinal and Poisonous Plants of Southern and Eastern Africa, 2nd ed. Livingstone, London.
49. Weniger, B., Robledo, S., Arango, G.J., Deharo, E., Aragòn, R., Muñoz, V., Callapa, J., Lobstein, A., Anton, R., 2001. Antiprotozoal activities of Colombian plants. Journal of Ethnopharmacology 78, 193-200. (Pubitemid 32994787)
50. World Health Organisation, 2010a. Tuberculosis. World Health Organisation, Geneva.
51. World Health Organisation, 2010b. Multidrug and Extensively Drug-resistant TB (M/XDR-TB): 2010 Global Report on Surveillance and Response. World Health Organisation, Geneva.
52. You, M., Ma, X., Mukherjee, R., Farnsworth, N.R., Cordell, G.A., Kinghorn, A.D., Pezzuto, J.M., 1994. Indole alkaloids from Peschiera laeta that enhances vinblastine-mediated cytotoxicity with multidrug-resistant cells. Journal of Natural Products 57, 1517-1522.
53. Zhu, J-P., Guggisberg, A., Kalt-Hadamowsky, M., Hesse, M., 1990. Chemotaxonomic study of the genus Tabernaemontana (Apocynaceae) based on their indole alkaloid content. Plant Systematics and Evolution 172, 13-34.